Contravisory Investment Management’s ResMed RMD Stock Holding History

Contravisory Investment Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,460	Closed	-$283K	–	291
2021 Q1	$283K	Sell	1,460 -28	-2%	-$5.62K	0.09%	140
2020 Q4	$316K	Sell	1,488 -182	-11%	-$36.3K	0.1%	114
2020 Q3	$286K	Hold	1,670	–	–	0.1%	121
2020 Q2	$282K	Buy	1,670 +1,648	+7,491%	+$270K	0.1%	113
2020 Q1	$3K	Buy	+22	New	+$3.5K	﹤0.01%	264
2019 Q2	–	Sell	-2,681	Closed	-$279K	–	318
2019 Q1	$279K	Sell	2,681 -29	-1%	-$2.99K	0.11%	123
2018 Q4	$309K	Buy	2,710 +2,662	+5,546%	+$285K	0.13%	98
2018 Q3	$6K	Hold	48	–	–	﹤0.01%	250
2018 Q2	$5K	Hold	48	–	–	﹤0.01%	296
2018 Q1	$5K	Hold	48	–	–	﹤0.01%	299
2017 Q4	$4K	Hold	48	–	–	﹤0.01%	304
2017 Q3	$4K	Buy	+48	New	+$3.67K	﹤0.01%	312

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Contravisory Investment Management's RMD Position: Q2 2021 in Review

Contravisory Investment Management sold out of ResMed (RMD) in Q2 2021, closing a stake of 1,460 shares — an estimated $283K sold.

Contravisory Investment Management first reported a position in RMD in Q3 2017 and held it in 12 quarters. The position peaked at $316K in Q4 2020. 661 funds tracked by Wall St. Rank hold RMD as of Q2 2021.

Contravisory Investment Management reported no remaining ResMed position as of Q2 2021 after selling out during the quarter.
Contravisory Investment Management sold 1,460 ResMed shares in Q2 2021, an estimated $283K.
Contravisory Investment Management first reported a position in ResMed in Q3 2017 and held it in 12 quarters.
Contravisory Investment Management's ResMed position peaked at $316K in Q4 2020.
661 funds tracked by Wall St. Rank held ResMed as of Q2 2021.

Based on Contravisory Investment Management's 13F filing for Q2 2021, filed 14 Jul 2021.